Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.

Abramson JS, Hellmann M, Barnes JA, Hammerman P, Toomey C, Takvorian T, Muzikansky A, Hochberg EP.

Cancer. 2010 Sep 15;116(18):4283-90. doi: 10.1002/cncr.25278.

2.

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy.

Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ.

Ann Oncol. 2010 May;21(5):1046-52. doi: 10.1093/annonc/mdp432. Epub 2009 Oct 27.

PMID:
19861575
3.
4.

Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.

Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI.

J Clin Oncol. 2009 Jan 1;27(1):114-9. doi: 10.1200/JCO.2008.16.8021. Epub 2008 Dec 1.

5.

Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomas.

Kinoshita M, Izumoto S, Hashimoto N, Kishima H, Kagawa N, Hashiba T, Chiba Y, Yoshimine T.

Brain Tumor Pathol. 2008;25(2):73-8. doi: 10.1007/s10014-008-0232-x. Epub 2008 Nov 6.

PMID:
18987832
6.

Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.

Jehan Z, Siraj AK, Abubaker J, Ruiz C, Simon R, Sultana M, Uddin S, Bavi P, Hussain A, Razack S, Ezzat A, Al-Dayel F, Sauter G, Al-Kuraya KS.

Oncology. 2008;75(1-2):71-80. doi: 10.1159/000155144. Epub 2008 Sep 12.

PMID:
18784434
7.

Evaluation of the modification of diet in renal disease study equation in a large diverse population.

Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, Levey AS.

J Am Soc Nephrol. 2007 Oct;18(10):2749-57. Epub 2007 Sep 12.

8.

Lymphoma dissemination: the other face of lymphocyte homing.

Pals ST, de Gorter DJ, Spaargaren M.

Blood. 2007 Nov 1;110(9):3102-11. Epub 2007 Jul 26. Review.

9.

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, Schmitz N; German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Ann Oncol. 2007 Jan;18(1):149-57. Epub 2006 Oct 3.

PMID:
17018708
10.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration.

Ann Intern Med. 2006 Aug 15;145(4):247-54. Erratum in: Ann Intern Med. 2008 Oct 7;149(7):519.

PMID:
16908915
11.

Imaging of renal lymphoma: patterns of disease with pathologic correlation.

Sheth S, Ali S, Fishman E.

Radiographics. 2006 Jul-Aug;26(4):1151-68. Review.

PMID:
16844939
12.

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.

Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH.

Blood. 2005 Jan 15;105(2):496-502. Epub 2004 Sep 9.

13.

Renal lesions associated with malignant lymphomas.

RICHMOND J, SHERMAN RS, DIAMOND HD, CRAVER LF.

Am J Med. 1962 Feb;32:184-207. No abstract available.

PMID:
14492019
14.

Malignant lymphomatosis of the kidneys.

WENTZELL RA, BERKHEISER SW.

J Urol. 1955 Aug;74(2):177-85. No abstract available.

PMID:
13252687
15.

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.

Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H.

Ann Oncol. 2002 Jul;13(7):1099-107.

PMID:
12176790
16.

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

National Kidney Foundation.

Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266. No abstract available.

PMID:
11904577
17.

Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients.

Da'as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, Goldfarb AW, Ben-Yehuda D.

Eur J Haematol. 2001 Sep;67(3):158-64.

PMID:
11737248
18.

Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis.

French CA, Dorfman DM, Shaheen G, Cibas ES.

Diagn Cytopathol. 2000 Dec;23(6):369-74.

PMID:
11074639
19.

Primary renal lymphoma does exist: case report and review of the literature.

Stallone G, Infante B, Manno C, Campobasso N, Pannarale G, Schena FP.

J Nephrol. 2000 Sep-Oct;13(5):367-72. Review.

PMID:
11063141
20.

Supplemental Content

Support Center